Author:
Kiselevskii M. V.,Vlasenko R. Ya.,Stepanyan N. G.,Shubina I. Zh.,Sitdikova S. M.,Kirgizov K. I.,Varfolomeeva S. R.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference23 articles.
1. Bernardo ME, Fibbe WE. Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell. 2013;13(4):392- 402. doi: https://doi.org/10.1016/j.stem.2013.09.006
2. Chan CK, Wu KH, Lee YS, Hwang SM, Lee MS, Liao SK, Cheng EH, See LC, Tsai CN, Kuo ML, Huang JL. The comparison of interleukin 6-associated immunosuppressive effects of human ESCs, fetal-type MSC, and adult-type MSC. Transplantation. 2012;94(2):132-138. doi: https://doi.org/10.1097/TP.0b013e31825940a4
3. Clinical Commissioning Policy: Treatments for Graft versus Host Disease (GvHD) following Haematopoietic Stem Cell Transplantation. 31 March 2017. URL: https://www.england.nhs.uk/wp-content/uploads/2017/03/gvhd-heamatopoieticstem- cell.pdf
4. Connard SS, Linardi RL, Even KM, Berglund AK, Schnabel LV, Ortved KF. Effects of continuous passage on the immunomodulatory properties of equine bone marrow-derived mesenchymal stem cells in vitro. Vet. Immunol. Immunopathol. 2021;234:110203. doi: https://doi.org/10.1016/j.vetimm.2021.110203
5. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317. doi: https://doi.org/10.1080/14653240600855905
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献